Quarterly report pursuant to Section 13 or 15(d)

Revenue Disaggregation

v3.22.4
Revenue Disaggregation
 9 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

 

Note 10. Revenue Disaggregation

 

The Company generates revenues from products which are sold into the human and animal healthcare markets and to multiple geographic regions.

 

The following table presents the Company’s disaggregated revenues by revenue source:

                       
   

Three Months Ended

December 31,

    

Nine Months Ended

December 31,

  
(In thousands)     2022       2021       2022       2021  
Human Care   $ 2,435     $ 2,015     $ 7,050     $ 7,201  
Animal Care     434       818       1,957       2,755  
Service and Royalty     75       69       1,251       374  
    $ 2,944     $ 2,902     $ 10,258     $ 10,330  

 

The following table shows the Company’s revenues by geographic region:

                       
   

Three Months Ended

December 31,

    

Nine Months Ended

December 31,

  
(In thousands)   2022     2021     2022     2021  
United States   $ 761     $ 933     $ 2,603     $ 3,872  
Europe     1,104       731       3,117       2,419  
Asia     514       664       1,952       1,810  
Latin America     384       273       1,827       1,356  
Rest of the World     181       301       759       873  
Total   $ 2,944     $ 2,902     $ 10,258     $ 10,330